Furthermore, we attempted to enucleate whether EGCG can enhance the proliferation inhibitory effect of cisplatin on gastric cancer cells by regulating the p19Arf-p53-p21Cip1 signaling pathway. This evidence concerns the gene TP53 and gastric cancer.